The rate of response to posaconazole was higher among patients with extrapulmonary aspergillosis (53%) than among those with pulmonary aspergillosis (39%), the results indicate.

• 泊沙康唑对肺外曲霉菌病患者疗效（53%25）高于肺内曲霉菌病患者疗效（39%25），研究结果表明。